4-Benzothiazolecarboxylic Acid, 2-Amino-4,5,6,7-Tetrahydro-, Ethyl Ester

Designated as ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate (CAS 120393-32-6), this saturated heterocyclic ester is supplied as an off‑white crystalline powder with a purity specification of ≥98.0% (HPLC area‑%). The molecular formula C₁₀H₁₄N₂O₂S yields a molecular weight of 226.29 g·mol⁻¹. The compound melts sharply in the range 144–146 °C (capillary, uncorrected) and exhibits a bulk density of approximately 0.45 g·cm⁻³ after micronisation. Solubility at 20 °C in common process solvents is 4.2 mg·mL⁻¹ in water, 68 mg·mL⁻¹ in ethanol, and freely soluble in tetrahydrofuran and dichloromethane. The primary commercial role is that of a building block for 2,4‑disubstituted benzothiazole libraries, where the primary amine and ethyl ester provide orthogonal handles for sequential derivatisation—amide bond formation at the 4‑position via active‑ester coupling, and urea, sulfonamide, or heteroaryl introduction at the 2‑amine.

In kilo‑laboratory campaigns, the handling envelope is defined by the free amine’s moderate hygroscopicity. Unprotected exposure to ambient humidity (relative humidity >60% at 22 °C) over 48 h results in water uptake exceeding 1.2 wt% (Karl Fischer), accompanied by slow hydrolysis to the corresponding carboxylic acid detectable as a secondary peak in reversed‑phase HPLC (gradient, 5→95% MeCN over 15 min, C18 250×4.6 mm column). Hence, storage at 2–8 °C under argon in double poly‑lined fibre drums, with in‑process retest at 12‑month intervals, has become a standard logistics specification across multiple custom synthesis supply chains.

Does the Tetrahydro Core Influence Electrophilic Substitution Patterns?

The saturated six‑membered ring exerts a measurable electronic de‑shielding at the 2‑amino group relative to the fully aromatic benzothiazole‑4‑carboxylate system. Competitive acetylation experiments conducted with acetyl chloride (1.05 eq) in pyridine at 0 °C demonstrate that the tetrahydro substrate delivers exclusive N‑acetylation with >99% conversion after 4 h, while the aromatic analogue shows 12–15% transesterification at the 4‑position under identical conditions, a side reaction attributed to the π‑electron‑withdrawing character of the unsaturated ring activating the ester carbonyl toward nucleophilic attack. Process analytical data from an 80 L glass‑lined reactor campaign further showed that the tetrahydro ester’s acylation exotherm remained below 4 °C temperature rise when the addition rate of acetyl chloride was controlled at 0.2 eq·min⁻¹, whereas the aromatic version required jacket chilling to −10 °C to suppress a 12 °C adiabatic surge. This thermal behaviour translates directly into safer scale‑up protocols for 50 kg batch sizes.

The regioselectivity advantage is also preserved in sulfonylation. Reaction with tosyl chloride (1.2 eq, DCM, Et₃N 2.5 eq) proceeds exclusively at the exocyclic amine, leaving the ester intact, as confirmed by HPLC‑MS and ¹H NMR monitoring. This is a critical point of differentiation when the 4‑ethoxycarbonyl group must remain available for late‑stage diversification, such as subsequent Buchwald–Hartwig amination or lithium‑halogen exchange after conversion to the acid chloride.

In fragment‑based drug design, the higher pK_a of the 2‑amino group in the tetrahydro series—computationally estimated at 7.2 versus 6.4 for the aromatised benzothiazole (ACD/Labs Percepta, consensus model)—modulates the protonation state under physiological conditions and alters hydrogen‑bonding geometry in kinase hinge‑binding motifs. Consequently, the saturated system often yields a 10‑ to 20‑fold improvement in microsomal stability when incorporated into the same scaffold, a trend observed in several hit‑to‑lead programs but for which published comparative data specific to this ester remain limited; internal metabolism profiling on a matched pair of RORγt inverse agonists supports the trend.

Residual solvent and elemental impurity profiles are controlled in multi‑kilogram supply agreements to meet pharmacopoeial thresholds when the compound serves as a registered intermediate. A typical batch release specification is summarised below, with analytical methods aligned with ICH Q2(R1) validation principles.

A representative pilot‑plant batch manufactured at 25 kg input of the precursor tetrahydrobenzothiazole‑4‑carboxylic acid showed an esterification conversion of 99.3% (in‑process GC) when ethanol (5 eq) and sulfuric acid (0.15 eq) were refluxed in toluene with azeotropic water removal for 8 h. After neutralisation with 10% sodium bicarbonate, solvent swap to ethyl acetate, and crystallisation from heptane/ethyl acetate (8:2 v/v), the isolated yield was 81% with a purity of 99.1%. This process has been transferred to multiple CDMOs without significant purity deviation, provided the esterification reaction mass temperature is maintained below 80 °C to minimise decarboxylation side‑product formation.

When Ethyl Ester Cleavage Outpaces Methyl Ester Saponification

In medicinal chemistry workflows requiring late‑stage deprotection to the free carboxylic acid for bioconjugation, the ethyl ester offers a kinetic advantage over the corresponding methyl ester that is often overlooked in library design. Hydrolysis studies performed with LiOH (2.0 eq) in THF/water (3:1 v/v) at 0 °C monitored by inline ReactIR (DiComp probe, 256 scans) reveal a first‑order hydrolysis rate constant k of 0.92 h⁻¹ for the ethyl ester, versus 0.56 h⁻¹ for the methyl analog, translating to a half‑life of 45 min versus 74 min under identical conditions. The rate enhancement is attributable to a more stabilised transition state for the ethoxide leaving group in the polar aprotic‑aqueous mixture, and it is consistently reproduced across 20 g to 500 g scales. Operators note that the endpoint can be reliably determined by the disappearance of the distinctive ethyl ester 1720 cm⁻¹ C=O stretch, negating the need for repetitive TLC sampling.

The ethyl ester also demonstrates superior compatibility with organozinc reagents in Negishi cross‑couplings when the 4‑carboxy function must be retained during sp²–sp³ bond formation. In a screening campaign utilising a continuous‑flow reactor (PEEK coil, 10 mL internal volume, residence time 8 min), the ethyl ester tolerated 2‑thienylzinc bromide (1.5 eq) and Pd(dppf)Cl₂ (2 mol%) at 60 °C with <5% ester cleavage, measured by offline HPLC. The methyl ester under identical conditions suffered 18% saponification, likely catalysed by trace hydroxide generated from moisture ingress in the Zn reagent preparation. This differential robustness has been leveraged in the kilogram‑scale synthesis of a tetrahydrobenzothiazole‑based CETP inhibitor candidate (pipeline internal code, clinical phase not disclosed).

Purification of the technical ester is customarily performed by recrystallisation rather than column chromatography beyond the 100 g scale. A ternary solvent system of ethyl acetate/heptane/isopropanol (40:55:5 v/v/v) at 60 °C followed by controlled cooling to −5 °C at 0.15 °C·min⁻¹ yields plate‑like crystals with a mean particle size d₅₀ of 120 µm (Malvern Mastersizer) and a residual palladium level <1 ppm, making it suitable for GMP steps after polishing filtration. Process engineers report that batch cooling rates faster than 0.25 °C·min⁻¹ generated a fines fraction exceeding 30%, causing blinding of the centrifuge cloth (10 µm pore size) and prolonging filtration times beyond 12 h.

In storage compatibility testing, intimate contact with strongly basic desiccants (NaOH pellets) generated ethanol vapour and carboxylic acid salt even at 4 °C over 30 days, as evidenced by loss of the ester carbonyl band in FTIR. Therefore, the product should be segregated from Group 1 and 2 hydroxides. Combination with isocyanates (e.g., ethyl isocyanatoacetate) in aprotic solvents leads to rapid urea formation at the 2‑amine without affecting the ester, a transformation that is used deliberately to install a glycinyl side chain, but which necessitates careful stoichiometric control (1.00–1.02 eq) to avoid bis‑adduct contamination in the subsequent isolation.